These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1431023)

  • 1. Treatment of depression in elderly patients with and without dementia disorders.
    Gottfries CG; Karlsson I; Nyth AL
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():55-64. PubMed ID: 1431023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment of elderly individuals with emotional disturbances: an open study with citalopram.
    Ragneskog H; Eriksson S; Karlsson I; Gottfries CG
    Int Psychogeriatr; 1996; 8(4):659-68. PubMed ID: 9147178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.
    Nyth AL; Gottfries CG
    Br J Psychiatry; 1990 Dec; 157():894-901. PubMed ID: 1705151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.
    Nyth AL; Gottfries CG; Lyby K; Smedegaard-Andersen L; Gylding-Sabroe J; Kristensen M; Refsum HE; Ofsti E; Eriksson S; Syversen S
    Acta Psychiatr Scand; 1992 Aug; 86(2):138-45. PubMed ID: 1529737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Citalopram in treatment of behavioral disorders in demented patients].
    Leblhuber F
    Acta Med Austriaca; 1994; 21(4):104-6. PubMed ID: 7871964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scandinavian experience with citalopram in the elderly.
    Gottfries CG
    Int Clin Psychopharmacol; 1996 Mar; 11 Suppl 1():41-4. PubMed ID: 8732444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double-blind comparison of the efficacy and safety of citalopram compared to mianserin in elderly, depressed patients with or without mild to moderate dementia.
    Karlsson I; Godderis J; Augusto De Mendonça Lima C; Nygaard H; Simányi M; Taal M; Eglin M
    Int J Geriatr Psychiatry; 2000 Apr; 15(4):295-305. PubMed ID: 10767728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citalopram dose-response revisited using an alternative psychometric approach to evaluate clinical effects of four fixed citalopram doses compared to placebo in patients with major depression.
    Bech P; Tanghøj P; Andersen HF; Overø K
    Psychopharmacology (Berl); 2002 Aug; 163(1):20-5. PubMed ID: 12185396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and management of depression in the elderly.
    Gottfries CG
    Int Clin Psychopharmacol; 1997 Dec; 12 Suppl 7():S31-6. PubMed ID: 9476138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of depressed demented patients.
    Alexopoulos GS
    J Clin Psychiatry; 1996; 57 Suppl 14():14-20. PubMed ID: 9024332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence.
    Henry G; Williamson D; Tampi RR
    Am J Alzheimers Dis Other Demen; 2011 May; 26(3):169-83. PubMed ID: 21429956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.
    Lavretsky H; Reinlieb M; St Cyr N; Siddarth P; Ercoli LM; Senturk D
    Am J Psychiatry; 2015 Jun; 172(6):561-9. PubMed ID: 25677354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.
    Soares CN; Poitras JR; Prouty J; Alexander AB; Shifren JL; Cohen LS
    J Clin Psychiatry; 2003 Apr; 64(4):473-9. PubMed ID: 12716252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia.
    Gottfries CG; Nyth AL
    Ann N Y Acad Sci; 1991; 640():276-9. PubMed ID: 1776751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Citalopram in depression--meta-analysis of intended and unintended effects.
    Bech P; Cialdella P
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():45-54. PubMed ID: 1431021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Citalopram, depression and pseudo dementia: a neuropsychological case study.
    Mattos P
    Arq Neuropsiquiatr; 1995 Dec; 53(4):841-8. PubMed ID: 8729786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind comparison of citalopram and placebo in depressed outpatients with melancholia.
    Mendels J; Kiev A; Fabre LF
    Depress Anxiety; 1999; 9(2):54-60. PubMed ID: 10207659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurobehavioral manifestation in early period of Alzheimer disease and vascular dementia].
    Bidzan M; Bidzan L
    Psychiatr Pol; 2014; 48(2):319-30. PubMed ID: 25016769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms.
    Fraguas R; da Silva Telles RM; Alves TC; Andrei AM; Rays J; Iosifescu DV; Wajngarten M
    Contemp Clin Trials; 2009 May; 30(3):205-11. PubMed ID: 19470312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of escitalopram in patients with severe depression: a pooled analysis.
    Llorca PM; Azorin JM; Despiegel N; Verpillat P
    Int J Clin Pract; 2005 Mar; 59(3):268-75. PubMed ID: 15857321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.